Mass production and size control of lipid-polymer hybrid nanoparticles through controlled microvortices
about
Can microfluidics address biomanufacturing challenges in drug/gene/cell therapies?Soft fluorescent nanomaterials for biological and biomedical imagingLipid-based surface engineering of PLGA nanoparticles for drug and gene delivery applicationsLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Ultra-high throughput synthesis of nanoparticles with homogeneous size distribution using a coaxial turbulent jet mixerHybrid soft-lithography/laser machined microchips for the parallel generation of droplets.Single step reconstitution of multifunctional high-density lipoprotein-derived nanomaterials using microfluidics.Microfluidic technologies for accelerating the clinical translation of nanoparticles.Liposomes in tissue engineering and regenerative medicineAntimicrobial properties of nanomolecules: potential candidates as antibiotics in the era of multi-drug resistance.Microfluidic platform for combinatorial synthesis and optimization of targeted nanoparticles for cancer therapy.HDL-mimetic PLGA nanoparticle to target atherosclerosis plaque macrophagesNanomedicines for Endothelial Disorders.Hybrid nanoparticles improve targeting to inflammatory macrophages through phagocytic signals.Synthesis of polymer-lipid nanoparticles for image-guided delivery of dual modality therapy.Probing nanoparticle translocation across the permeable endothelium in experimental atherosclerosis.Parallel microfluidic synthesis of size-tunable polymeric nanoparticles using 3D flow focusing towards in vivo study.Lipid-enveloped hybrid nanoparticles for drug delivery.Merging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery.Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies.Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines.Microfluidics-mediated assembly of functional nanoparticles for cancer-related pharmaceutical applications.Microfluidic Synthesis of Nanohybrids.Nanomedicines for renal disease: current status and future applicationsCancer nanomedicine: progress, challenges and opportunities.Receptor-mediated membrane adhesion of lipid-polymer hybrid (LPH) nanoparticles studied by dissipative particle dynamics simulations.Microfluidic-assisted fabrication of carriers for controlled drug delivery.Hyaluronic Acid-Based Nanogels Produced by Microfluidics-Facilitated Self-Assembly Improves the Safety Profile of the Cationic Host Defense Peptide Novicidin.Multiscale technologies for treatment of ischemic cardiomyopathy.Robust manufacturing of lipid-polymer nanoparticles through feedback control of parallelized swirling microvortices.A versatile and robust microfluidic platform toward high throughput synthesis of homogeneous nanoparticles with tunable properties.PDMS-based turbulent microfluidic mixer.Microfluidic platforms with monolithically integrated hierarchical apertures for the facile and rapid formation of cargo-carrying vesicles.Rapid transport of deformation-tuned nanoparticles across biological hydrogels and cellular barriers.Vapor sublimation and deposition to build porous particles and composites.Tunable Rigidity of (Polymeric Core)-(Lipid Shell) Nanoparticles for Regulated Cellular Uptake
P2860
Q26752073-095885EA-AB36-440E-AE82-43368E80DD6CQ26866189-CA44F9F0-43B7-4844-B0FB-B12926F0A6B3Q28076544-11879106-E637-40B0-8AF2-D4AAA8608F6BQ30366990-C1ACAF60-3D02-49DA-A765-CD1E03C87C04Q30581724-6D78CA98-2D83-45BB-8988-4BCE4385EAB2Q30647803-4BE38A68-B70F-4269-B9DE-3B008F4DFFB8Q33924365-C0C862AB-2F7F-425D-BFC6-E663034C1A76Q34435740-C44AB311-830A-420B-94D2-F42CEA77CAE2Q34470412-C4E1BD6D-4333-42D7-AFFA-2B51220A9C09Q34476113-9DF9438D-382A-4FA5-A17E-ABDA5BECD150Q35038416-CC438ACF-3B2C-472C-9081-2AC54F748D72Q35795262-3A211E97-E3C6-447D-B407-CF17A7AFC6E1Q36651592-48ED6BFE-5BA8-43A0-B838-B4697641678AQ36920492-E291F23D-031B-4ABD-870C-5EC1C2A20AFBQ37260459-E884785E-D495-4E65-A5F1-73BDB88EBAF2Q37519622-4B84C9A2-625E-4A09-85E8-B42FC3CD9D42Q37634173-88140A98-FBE2-418E-A434-8D5AD0C54CA0Q38071910-A73EBEAE-1876-4460-A4EA-FB169933E6E3Q38150118-53CF0C97-E454-41E5-B2D4-65197CC06F8FQ38166550-8E580C3B-6B96-4080-BD03-907D005E9D75Q38676164-958446B4-96F5-4817-A997-93CFBEFF7BA4Q38728839-16296E55-9102-4074-97C7-C28340ADE4F1Q38751147-EB546B80-7273-4323-AFE2-C22C71DC3DC8Q38802375-9AEAB8CE-8E75-416D-88BD-7F810CD54212Q39005226-1D3E1A69-284C-46FD-A1C8-743EABE5116BQ39092041-BB9EF961-5AEB-4374-9A7A-F522463DA9AAQ39289983-464AB273-E74E-42AC-A1D9-D3C62A541ADBQ42829020-D4ECE2D3-9829-4FA8-A7B0-5EFCC1D41A13Q46454164-AF9E3819-F099-4DAA-B4CB-E82C379E187FQ47903206-F07A9736-42D4-44E6-99F2-AE3FA4CEDA99Q51499008-82EE001D-1240-4959-9408-DEBE4644FD6BQ51499351-D510781B-DD38-4869-BCDB-53EC76F37EEFQ51504367-84EC639F-4B65-49BA-ADE2-9DA6478AE0F4Q55448277-EAF38D91-2835-4A00-8F08-04BCCD1DD9E9Q55517615-2048CA55-D83D-4103-94FD-111749238978Q57238665-562EB2B1-6676-4BBA-B012-D4F907B98063
P2860
Mass production and size control of lipid-polymer hybrid nanoparticles through controlled microvortices
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Mass production and size contr ...... rough controlled microvortices
@ast
Mass production and size contr ...... rough controlled microvortices
@en
type
label
Mass production and size contr ...... rough controlled microvortices
@ast
Mass production and size contr ...... rough controlled microvortices
@en
prefLabel
Mass production and size contr ...... rough controlled microvortices
@ast
Mass production and size contr ...... rough controlled microvortices
@en
P2093
P2860
P50
P356
P1433
P1476
Mass production and size contr ...... rough controlled microvortices
@en
P2093
Bomy Lee Chung
Robert Langer
Zahi A Fayad
P2860
P304
P356
10.1021/NL301253V
P407
P577
2012-06-20T00:00:00Z